SCC |
Squamous cell carcinoma |
NMSCs |
Non-melanoma skin cancers |
BCC |
Basal cell carcinoma |
UV |
Ultraviolet |
ROS |
Reactive oxygen species |
RNS |
Reactive nitrogen species |
HPV |
Human papillomavirus |
AK |
Actinic keratosis |
BD |
Bowen’s disease |
SC |
Stratum corneum |
EPR |
Enhanced permeability and retention effect |
PDT |
Photodynamic therapy |
5-FU |
5-Fluorouracil |
API |
Active pharmaceutical ingredient |
DMSO |
Dimethylsulfoxide |
SLNs |
Solid lipid nanoparticles |
NLCs |
Nanostructured lipid carriers |
AgNPs |
Silver nanoparticles |
AuNPs |
Gold nanoparticles |
STING |
Stimulator of Interferon Genes |
BCS |
Biopharmaceutical classification system |
IMQ |
Imiquimod |
FDA |
United States Food and Drug Administration |
EMA |
European Medicines Agency |
ADP |
Adenosine diphosphate ribose |
COX-2 |
Cyclooxygenase-2 |
PGE2 |
Prostaglandin E2 |
IM |
Ingenol mebutate |
VD3A |
Vitamin D3 analogs |
VDR |
Vitamin D receptor |
RARs |
Retinoic acid receptors |
RXRs |
Retinoid X receptors |
CTCL |
Cutaneous T-cell lymphoma |
STAT3 |
Signal Transducer and Activator of Transcription 3 |
siRNA |
Small interfering RNA |